GL1X · GenesisL1 explorer

MolNFT v1 · #145723 · protein

Crystal structure of spaa-slh in complex with 4,6-pyr-beta-D-mannacome (C2)

6CWI · Surface (S-) layer glycoprotein: “Crystal structure of spaa-slh in complex with 4,6-pyr-beta-D-mannacome (C2)”. X-ray diffraction, 2 ligands (6LA, SO4), 2 pockets (best druggability 0.56). MolNFT v1 #145723 on GenesisL1: 3D…

PDB
6CWI
Type
protein
Length
329 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Surface (S-) layer glycoprotein
UniProt
C1JZ07
Ligands
6LA, SO4
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASurface (S-) layer glycoproteinprotein16541% helix, 4% strandC1JZ07
BSurface (S-) layer glycoproteinprotein16443% helix, 4% strandC1JZ07

Ligands and binding sites

  • 6LA · methyl 2-(acetylamino)-4,6-O-[(1S)-1-carboxyethylidene]-2-deoxy-beta-D-mannopyranoside · ligand · 3 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12560.560.7733empty
2570.360.79136LA

Interfaces

1 interface between chains.

  • A–B · 465 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 6CWI · Crystal structure of SpaA-SLH in complex with 4,6-Pyr-beta-D-ManNAcOMe (C2) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.